Chose to fly on Malaysian Airlines: from Amsterdam to Melbourne for 20th Int. AIDS Conf.
Prof LANGE supported Pre-exposure prophylaxsis (PREP) against HIV. using a combination drug such as TRUVADA (tenofovir + emtricitabine) made by California GILEAD SCIENCES (NASDAQ) Net income 2013 $3-billion.Cost:TRUVADA USD$1,000/month. Reduces HIV incidence by 51%.
